Newswise — New questions are at the forefront as a study published in the Journal of Clinical Microbiology from nine children’s hospitals finds that most asymptomatic children who tested positive for COVID-19 had relatively low levels of the virus compared to symptomatic children. The authors caution that the reason for this finding is unclear and more questions need to be answered. Were the asymptomatic children generally tested later in their disease, and were their viral loads potentially higher closer to the beginning of their infections? If tested early in disease, would asymptomatic children have viral loads as high as symptomatic children? Or do asymptomatic children typically not carry as much virus as children with symptoms? If so, how would lower viral loads impact the risk of transmission? These questions are essential to further clarify the public health impact of pediatric COVID-19.

“While these findings provide some reassurance about the safety of asymptomatically infected children attending school, these unanswered questions suggest that risk mitigation measures in daycares, schools and the community remain critical to reduce the spread of COVID-19. Children must continue to wear masks, maintain social distance and wash their hands frequently,” said first author Larry Kociolek, MD, pediatric infectious diseases expert at Ann & Robert H. Lurie Children’s Hospital of Chicago and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “At this stage, we can’t predict which children are likely to carry more or less virus, because in every age group we tested, there were some asymptomatic kids with a higher viral load.  However, even the groups of asymptomatic kids with highest viral load in our study still had lower viral loads than the children with symptoms.”

The study included 339 asymptomatic and 478 symptomatic children (ages 0-17 years) matched by age groups. All children in the study screened positive for COVID-19 using PCR tests at nine children’s hospitals across the United States and Canada. To be able to combine PCR data from the different assays used at the nine institutions, the team adjusted cycle threshold (Ct) values by centering each value around the institutional median Ct value from symptomatic children tested with that assay, and also converted them to estimated viral loads (copies/mL).  It is the first large and comprehensive investigation into SARS-CoV-2 viral loads in asymptomatic children.

The analysis demonstrated that asymptomatic children with diabetes and/or recent contact with a COVID-19 case, as well as those tested for surveillance purposes (rather than for pre-procedure or pre-admission purposes), had significantly higher estimated risk of being in the quartile with the highest viral burden.  The authors note that the finding that patients more likely to have recent infections (contact/surveillance) were more likely to have higher viral loads suggests that timing of infection relative to diagnostic testing impacted the viral loads in the asymptomatic kids in the study.  However, they also note that even in the asymptomatic surveillance sub-cohort with highest viral loads, median viral loads were still significantly lower than in the symptomatic cohort. 

“We now need to know what the peak viral loads are in asymptomatic kids with COVID-19,” said principal investigator and senior author Nira Pollock, MD, PhD, Associate Medical Director of the Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital and Associate Professor of Pathology and Medicine at Harvard Medical School. “Did the timing of testing just miss the peak in many of the asymptomatic kids in this study, or do asymptomatic kids actually have lower peak viral loads than symptomatic kids?”

The authors also point out that the levels of the virus they found in the asymptomatic children were mostly lower than the levels that the available rapid antigen tests are able to detect.

“It is important to recognize that rapid antigen tests are less sensitive than the PCR tests used in hospitals, and that many of the asymptomatic kids in our study likely would have tested negative using the rapid tests based on our understanding of the limits of detection of those tests,” said Dr. Pollock. “Our findings should raise caution about using low sensitivity tests for asymptomatic screening programs in pediatric populations. Overall, we want to encourage more studies to better understand the viral loads in asymptomatic kids—particularly peak viral loads early in infection.”

Research at Ann & Robert H. Lurie Children’s Hospital of Chicago is conducted through the Stanley Manne Children’s Research Institute. The Manne Research Institute is focused on improving child health, transforming pediatric medicine and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children’s is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report. It is the pediatric training ground for Northwestern University Feinberg School of Medicine. Last year, the hospital served more than 220,000 children from 48 states and 49 countries.

Boston Children’s Hospital is ranked the #1 children’s hospital in the nation by U.S. News & World Report and is the primary pediatric teaching affiliate of Harvard Medical School. Home to the world’s largest research enterprise based at a pediatric medical center, its discoveries have benefited both children and adults since 1869. Today, 3,000 researchers and scientific staff, including 9 members of the National Academy of Sciences, 21 members of the National Academy of Medicine and 12 Howard Hughes Medical Investigators comprise Boston Children’s research community. Founded as a 20-bed hospital for children, Boston Children’s is now a 415-bed comprehensive center for pediatric and adolescent health care. For more, visit our Discoveries blog and follow us on social media @BostonChildrens@BCH_InnovationFacebook and YouTube.

Journal Link: Journal of Clinical Microbiology, Oct-2020

MEDIA CONTACT
Register for reporter access to contact details
RELATED EXPERTS
CITATIONS

Journal of Clinical Microbiology, Oct-2020

Download PDF
160338615034577_Journal of Clinical Microbiology-2020-Kociolek-JCM.02593-20.full.pdf